
Avantor’s third quarter results were met with a significant negative market reaction, reflecting investor concerns surrounding both the scale and persistence of operational headwinds. Management explicitly acknowledged disappointing performance, with CEO Emmanuel Ligner describing the period as marked by "self-inflicted" challenges in commercial and operational execution. Ligner attributed underwhelming revenue trends to complexity in the go-to-market model, weak customer activity in laboratory solutions, and ongoing production issues in bioprocessing. He also emphasized that recent share losses, particularly in the lab segment, were exacerbated by inadequate empowerment of frontline commercial teams and underinvestment in supply chain reliability.
Is now the time to buy AVTR? Find out in our full research report (it’s free for active Edge members).
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
In upcoming quarters, the StockStory team will monitor (1) evidence of operational improvements in bioprocessing, particularly reduced backlogs and increased plant efficiency; (2) progress in digital platform enhancements and salesforce empowerment within laboratory solutions; and (3) the impact of leadership changes and new hires on execution and accountability. We will also watch for updates on the company’s cost transformation program and any portfolio adjustments aimed at sharpening focus and profitability.
Avantor currently trades at $11.50, down from $15.07 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free for active Edge members).
Fresh US-China trade tensions just tanked stocks—but strong bank earnings are fueling a sharp rebound. Don’t miss the bounce.
Don’t let fear keep you from great opportunities and take a look at Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Jul-30 | |
| Jul-29 | |
| Jul-29 | |
| Jul-29 | |
| Jul-14 | |
| Jul-01 | |
| May-19 | |
| Apr-29 | |
| Apr-29 | |
| Apr-29 | |
| Apr-23 | |
| Apr-21 | |
| Apr-16 | |
| Apr-13 | |
| Apr-03 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite